8-K
Current Report
Protalix BioTherapeutics, Inc. Filed Acc 0001144204-17-053341
Shareholder vote results
- Item 5.07 Submission of matters to a vote of security holders
From the SEC's structured data for this filing
Loading tv477388_8k.htm…